摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

甘油1,3-二硝酸酯 | 623-87-0

中文名称
甘油1,3-二硝酸酯
中文别名
1,3-二硝基丙三醇
英文名称
1,3-bis(nitrooxy)propan-2-ol
英文别名
glycerol 1,3-dinitrate;1,3-Dinitroglycerin;(2-hydroxy-3-nitrooxypropyl) nitrate
甘油1,3-二硝酸酯化学式
CAS
623-87-0
化学式
C3H6N2O7
mdl
MFCD00661061
分子量
182.09
InChiKey
ASIGVDLTBLZXNC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    26°C
  • 沸点:
    315.45°C (rough estimate)
  • 密度:
    1.5230
  • 闪点:
    2℃

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    12
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    130
  • 氢给体数:
    1
  • 氢受体数:
    7

ADMET

毒理性
  • 副作用
高铁血红蛋白血症 - 血液中高铁血红蛋白含量增加;该化合物被归类为次要的毒性效应。
Methemoglobinemia - The presence of increased methemoglobin in the blood; the compound is classified as secondary toxic effect
来源:Haz-Map, Information on Hazardous Chemicals and Occupational Diseases

安全信息

  • 危险等级:
    1.1A
  • 危险品标志:
    F,Xn
  • 安全说明:
    S16,S36/37
  • 危险类别码:
    R11,R20/21/22,R36
  • WGK Germany:
    2
  • 危险品运输编号:
    0473
  • 海关编码:
    2920909090
  • 包装等级:
    II
  • 危险类别:
    1.1A
  • 储存条件:
    `-20°C`

SDS

SDS:cfdb03faebddebdd656f58a6ca03afbf
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    甘油1,3-二硝酸酯硝酸 作用下, 生成 硝酸甘油
    参考文献:
    名称:
    Study of nitration equilibrium in the glycerin-aqueous nitric acid system. 1. Dependence of the equilibrium constants of nitration reactions on the temperature, acidity of the medium, and structure of the nitrated compound
    摘要:
    The equilibrium constants of seven sequential-parallel reactions of conversion of glycerin into glycerin trinitrate in aqueous HNO3 were measured. The effect of the acidity of the medium on the equilibrium nitration constants is correlated with processes of protonation of glycerin and its nitrates. The equilibrium nitration constants are higher for primary hydroxides than for secondary hydroxides, and they decrease in both series in going from glycerin to its dinitrates.
    DOI:
    10.1007/bf00961477
  • 作为产物:
    描述:
    硝酸甘油 作用下, 生成 甘油1,3-二硝酸酯
    参考文献:
    名称:
    Study of nitration equilibrium in the glycerin-aqueous nitric acid system. 1. Dependence of the equilibrium constants of nitration reactions on the temperature, acidity of the medium, and structure of the nitrated compound
    摘要:
    The equilibrium constants of seven sequential-parallel reactions of conversion of glycerin into glycerin trinitrate in aqueous HNO3 were measured. The effect of the acidity of the medium on the equilibrium nitration constants is correlated with processes of protonation of glycerin and its nitrates. The equilibrium nitration constants are higher for primary hydroxides than for secondary hydroxides, and they decrease in both series in going from glycerin to its dinitrates.
    DOI:
    10.1007/bf00961477
点击查看最新优质反应信息

文献信息

  • Analogs of 2-Arachidonoylglycerin containing the no-donor group
    作者:I. V. Serkov、N. M. Gretskaya、V. V. Bezuglov
    DOI:10.1007/s10600-012-0253-x
    日期:2012.7
    1,3-Dinitroglyceryl esters of fatty acids, analogs of endocannabinoid 2-arachidonoylglycerin, were synthesized. Various methods for esterifying fatty acids with glycerine dinitrate were developed.
    具有脂肪酸酯结构、类似内源性大麻素2-花生四烯酸甘油酯的1,3-二硝酸甘油酯衍生物被合成。研究了多种将脂肪酸与二硝酸甘油酯化的方法。
  • NO-RELEASING NITROOXY-CHROMENE CONJUGATES
    申请人:EUCLISES PHARMACEUTICALS, INC.
    公开号:US20160340330A1
    公开(公告)日:2016-11-24
    The present invention provides NO-releasing nitrooxy-alkylenyl-linked-chromene conjugates, having the structure of Formula (1) wherein R1, R2, R3, R4, X, and L are as defined in the detailed description; pharmaceutical compositions comprising at least one compound o Formula (I); and methods useful for healing wounds, preventing and treating cancer and treating actinic keratosis, cystic fibrosis, and acne, using a compound of Formula (1).
    本发明提供了NO释放的硝基氧烷基连接的色酮共轭物,其具有如下式(1)的结构,其中R1、R2、R3、R4、X和L如详细描述中所定义;包含至少一种Formula(I)化合物的药物组合物;以及使用Formula(1)化合物有益于愈合伤口、预防和治疗癌症以及治疗光老化性角化症、囊性纤维化和痤疮的方法。
  • Dinitroglyceryl and diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of aspirin, indomethacin and ibuprofen: Synthesis, biological evaluation and nitric oxide release studies
    作者:Khaled R.A. Abdellatif、Morshed Alam Chowdhury、Ying Dong、Dipankar Das、Gang Yu、Carlos A. Velázquez、Mavanur R. Suresh、Edward E. Knaus
    DOI:10.1016/j.bmcl.2009.04.059
    日期:2009.6
    anti-inflammatory (AI) ester prodrugs (NONO-NSAIDs) wherein a 1,3-dinitrooxy-2-propyl (12a–c), or O2-acetoxymethyl-1-[2-(methyl)pyrrolidin-1-yl]diazen-1-ium-1,2-diolate (14a–c), NO-donor moiety is directly attached to the carboxylic acid group of aspirin, indomethacin or ibuprofen were synthesized. NO release from the dinitrooxypropyl, or diazen-1-ium-1,2-diolate, ester prodrugs was increased substantially
    混合一氧化氮的一组新的(NO)释放抗炎(AI)酯前药(NONO-的NSAIDs),其中1,3- dinitrooxy -2-丙基(12A - ç),或Ô 2 -acetoxymethyl -1- [ 2 - (甲基)吡咯烷-1-基]二氮烯-1-鎓-1,2-二醇盐(14A - ç),NO供体部分直接连接于阿司匹林的羧酸基团,吲哚美辛或布洛芬合成。在l-半胱氨酸(12a - c)或大鼠血清(14a - c)。不抑制COX-1同工酶的酯前药(12a – c,14a – c)对COX-2同工酶表现出适度的抑制活性。NONO-NSAID 12a – c和14a – c当给予相同的口服剂量(μmol/ kg)时,其体内AI活性类似于母体药物阿司匹林,吲哚美辛或布洛芬。口服药效学特征的这些相似性表明,这些NONO-NSAIDs是经典的前药,需要通过酯酶介导的水解作用来进行代谢活化。这种混合的NO供体/抗
  • Syntheses, Calcium Channel Agonist−Antagonist Modulation Activities, and Nitric Oxide Release Studies of Nitrooxyalkyl 1,4-Dihydro-2,6-dimethyl-3-nitro-4-(2,1,3-benzoxadiazol-4-yl)pyridine-5-carboxylate Racemates, Enantiomers, and Diastereomers
    作者:Rudong Shan、Carlos Velazquez、Edward E. Knaus
    DOI:10.1021/jm030333h
    日期:2004.1.1
    A novel group of hybrid calcium channel (CC) modulators was prepared where the isopropyl ester moiety of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2,1,3-benzoxadiazol-4-yl)pyridine-5-carboxyla te (PN 202-791) was replaced by a variety of nitric oxide (*NO) donor nitrooxyalkyl ester substituents. Enantiomers, or diastereomers, having the (R)-configuration at the C-4 position of the 1,4-dihydropyridine
    制备了一组新的杂化钙通道(CC)调节剂,其中异丙基1,4-二氢-2,6-二甲基-3-硝基-4-(2,1,3-苯并恶二唑-4-基)的异丙基酯部分吡啶5-羧基(PN 202-791)被各种一氧化氮(* NO)供体硝基氧基烷基酯取代基取代。在1,4-二氢吡啶环(1,4-DHP)的C-4位具有(R)构型的对映异构体或非对映异构体对豚鼠回肠纵向平滑肌(GPILSM)表现出更有效的体外CC拮抗剂活性),而不是具有(4S)-构型的化合物。硝基氧烷基化合物均未对GPILSM表现出禁忌的CC激动剂作用,该作用会引起平滑肌收缩。结构活性研究表明,对映异构体在1的C-4位置具有(S)-构型 在1,4-DHP环的C-4位置具有(4S)构型的4-DHP环或非对映异构体与(1R-)-1-甲基-2-硝基氧乙基酯取代基一起显示出最有效的豚鼠左心房(GPLA)的心脏CC激动剂(正性肌力)活性。这类化合物在体外释放* NO,
  • Photoactive energetic materials
    申请人:LOS ALAMOS NATIONAL SECURITY, LLC.
    公开号:US09902748B2
    公开(公告)日:2018-02-27
    Energetic materials that are photoactive or believed to be photoactive may include a conventional explosive (e.g. PETN, nitroglycerine) derivatized with an energetic UV-absorbing and/or VIS-absorbing chromophore such as 1,2,4,5-tetrazine or 1,3,5-triazine. Absorption of laser light having a suitably chosen wavelength may result in photodissociation, decomposition, and explosive release of energy. These materials may be used as ligands to form complexes. Coordination compounds include such complexes with counterions. Some having the formula M(L)n2+ were synthesized, wherein M is a transition metal and L is a ligand and n is 2 or 3. These may be photoactive upon exposure to a laser light beam having an appropriate wavelength of UV light, near-IR and/or visible light. Photoactive materials also include coordination compounds bearing non-energetic ligands; in this case, the counterion may be an oxidant such as perchlorate.
    具有光活性或被认为具有光活性的活性材料可能包括与能量吸收紫外线和/或可见光色团(如1,2,4,5-四唑或1,3,5-三唑)衍生的传统爆炸物(例如PETN,硝化甘油)。吸收具有适当选择波长的激光光线可能导致光解、分解和爆炸释放能量。这些材料可以用作配体形成配合物。配位化合物包括具有对离子的这些配合物。一些具有M(L)n2+公式的化合物已经合成,其中M是过渡金属,L是配体,n为2或3。这些化合物在暴露于具有适当波长的紫外线、近红外和/或可见光的激光光束时可能具有光活性。光活性材料还包括携带非活性配体的配位化合物;在这种情况下,对离子可能是诸如高氯酸盐之类的氧化剂。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台